Last checked at 
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Says that AxisBiotix Ltd, a wholly owned subsidiary, has finalised the analysis of the data from its AxisBiotix Acne food supplement consumer study. Participant feedback was highly positive - 84% reported that the appearance of their spots had improved; 77% reported that the pain caused by their spots had eased; 62% reported that the anxiety they felt due to their spots had improved; and 58% reported that the impact their spots had on their social life had improved. Chief Executive Stuart Ashman says: "We still have some work to do on end formulation but our focus is very much on commercialisation."
----------
Blackbird PLC - London-based technology licensor, developer and seller of cloud video editing platform - Issues trading update ahead of Tuesday's annual general meeting. Says In advance of marketing, elevate.io is in the planned general release phase and, although not yet at a chargeable grade, currently has early adopters in the high hundreds. A prototype of elevate.io platform will be demonstrated after the AGM. Targetting earnings before interest, tax, depreciation and amortisation breakeven for Blackbird division in 2024. Strongly believes the strategy is the right one.
----------
Chesterfield Resources PLC - copper and gold explorer in Cyprus and Labrador, Canada - Sells the eastern Canadian Adeline copper exploration project for around GBP550,000 in cash and shares to Sterling Metals, the TSX-V listed Canadian exploration company. Sterling will pay Chesterfield CAD200,000, around GBP115,000, and issue 8.5 million Sterling shares to Chesterfield. This will give Chesterfield a 5.5% stake in Sterling. Chesterfield says sale removes the uncertainty over Sterling's exercise of their option to acquire Adeline which may not have been finally known for several months. In addition, the deal strengthens Chesterfield's balance sheet. "The company is well funded and expects strong news flow in the months ahead as it works to emerge as a leading Canadian copper explorer," Chesterfield says. Can now evaluate the exploration plans in Cyprus as well as additional opportunities with the confidence of this increased non dilutive funding.
----------
Oxford Biomedica PLC - gene and cell-therapy company - Applies for listing of 5.2 million shares, 4.9% of its share capital. This follows confirmation of GBP16.9 million investment by TSGH SAS, a subsidiary of Institut Mérieux SA, at 325 pence per share. This investment follows Oxford Biomedica's acquisition of ABL Europe SAS from Institut Merieux, completed in January. Institut Merieux will hold an around 11% stake in Oxford Biomedica.
----------
Intercede Group PLC - Lutterworth, England-based cybersecurity software firm - In the financial year to March 31, says pretax profit balloons to GBP5.6 million from GBP0.6 million a year prior, as revenue leaps 65% to GBP20.0 million from GBP12.1 million. Basic earnings per share climbs to 10.3 pence from 2.3p. Net margin near triples to 30% from 11%. Describes financial year as "exceptional". No dividend proposed, unchanged.
----------
Clean Power Hydrogen PLC - Doncaster, England-based green hydrogen technology and manufacturing company - Awarded CE marking for the process of making its electrolyser stacks, having received a Declaration of Conformity following an independent assessment. The stacks are a key component of the electrolysers, which will be made at the facility in Doncaster as well as sold to license partners. The CE marking illustrates that the company manufactures the stacks within the EU directives and harmonised standards and is an important milestone towards commercial readiness. Chief Executive Jon Duffy comments: "We are committed to developing a safe, sustainable product and our priority continues to be reaching commercialisation and delivery of our MFE technology."
----------
Verici Dx PLC - develops advanced clinical diagnostics for organ transplants -
Completes the successful transfer of a portion of the company's urine samples as announced as part of the global commercialisation and licensing agreement announced in November 2023. As previously stated, this demonstrates the additional value in the company's data and sample assets for research. Chief Executive Sara Barrington says: "This achievement not only highlights our commitment to delivering on our agreements, but also underscores the substantial value inherent in the company's data and sample assets for research purposes."
----------
Cobra Resources PLC - rare earth minerals miner - Announces that ongoing in situ recovery bench scale testing of a core sample from Boland has revealed an exceptionally high head grade, enriched in high value magnet and heavy rare earth metals. A second sample is being prepared for further bench scale ISR studies. Further, says metallurgical testing by the Australian Nuclear Science and Technology Organisation aimed at demonstrating the suitability for ISR mining is nearing completion, with full results expected by the end of June.
----------
DCI Advisors Ltd - British Virgin Islands-based investor in the luxury residential resort sector - Updates with regard to results for 2023. DCI has been informed that its auditor KPMG Cyprus had, as of June 4, not started the audit due to operational issues at KPMG Greece, and therefore the audit is expected to take until at least August 9. DCI intends to issue unaudited results for 2023 on June 28. But does not expect to release audited figures until mid-August. Does not expect any material differences between the two. But as per listing rules, requests suspension of shares until audited results are published.
----------
Cordel Group PLC - London-based company, whose flagship platform uses artificial intelligence to supply transport corridor analytics - Announces a significant new customer win in the Middle East. The end customer operates a major rail network. This initial six-month project, valued at GBP370,000, marks Cordel's first contract win in the Middle East. Chief Executive John Davis says: "We are thrilled to establish our presence in the Middle East, an important target geography, with this significant customer engagement."
----------
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.